Literature DB >> 26747779

Lipopolysaccharide induces ICAM-1 expression via a c-Src/NADPH oxidase/ROS-dependent NF-κB pathway in human pulmonary alveolar epithelial cells.

Rou-Ling Cho1, Chien-Chung Yang2, I-Ta Lee1, Chih-Chung Lin3, Pei-Ling Chi1, Li-Der Hsiao3, Chuen-Mao Yang4.   

Abstract

Upregulation of intercellular adhesion molecule-1 (ICAM-1) is frequently implicated in lung inflammation. Lipopolysaccharide (LPS) has been shown to play a key role in inflammation via adhesion molecule induction and then causes lung injury. However, the mechanisms underlying LPS-induced ICAM-1 expression in human pulmonary alveolar epithelial cells (HPAEpiCs) remain unclear. We showed that LPS induced ICAM-1 expression in HPAEpiCs, revealed by Western blotting, RT-PCR, real-time PCR, and promoter assay. Pretreatment with the inhibitor of c-Src (protein phosphatase-1, PP1), reactive oxygen species (ROS) (Edaravone), NADPH oxidase (apocynin and diphenyleneiodonium chloride), EGFR (AG1478), PDGFR (AG1296), phosphatidylinositol-3-kinase (PI3K) (LY294002), MEK1/2 (U0126), or NF-κB (Bay11-7082) and transfection with siRNAs of c-Src, EGFR, PDGFR, Akt, p47(phox), Nox2, Nox4, p42, and p65 markedly reduced LPS-induced ICAM-1 expression and monocyte adherence to HPAEpiCs challenged with LPS. In addition, we established that LPS stimulated phosphorylation of c-Src, EGFR, PDGFR, Akt, or p65, which was inhibited by pretreatment with their respective inhibitors. LPS induced Toll-like receptor 4 (TLR4), MyD88, TNF receptor-associated factor 6 (TRAF6), c-Src, p47(phox), and Rac1 complex formation 2, which was attenuated by transfection with c-Src or TRAF6 siRNA. Furthermore, LPS markedly enhanced NADPH oxidase activation and intracellular ROS generation, which were inhibited by PP1. We established that LPS induced p42/p44 MAPK activation via a c-Src/NADPH oxidase/ROS/EGFR, PDGFR/PI3K/Akt-dependent pathway in these cells. Finally, we observed that LPS significantly enhanced NF-κB and IκBα phosphorylation, NF-κB translocation, and NF-κB promoter activity, which were inhibited by PP1, Edaravone, apocynin, diphenyleneiodonium chloride, AG1478, AG1296, LY294002, or U0126. These results demonstrated that LPS induces p42/p44 MAPK activation mediated through the TLR4/MyD88/TRAF6/c-Src/NADPH oxidase/ROS/EGFR, PDGFR/PI3K/Akt pathway, which in turn initiates the activation of NF-κB and ultimately induces ICAM-1 expression in HPAEpiCs.
Copyright © 2016 the American Physiological Society.

Entities:  

Keywords:  adhesion molecules; lipopolysaccharide; lung inflammation; signaling pathway; transcription factor

Mesh:

Substances:

Year:  2016        PMID: 26747779     DOI: 10.1152/ajplung.00109.2014

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  20 in total

1.  Rho and Reactive Oxygen Species at Crossroads of Endothelial Permeability and Inflammation.

Authors:  Pratap Karki; Konstantin G Birukov
Journal:  Antioxid Redox Signal       Date:  2019-06-28       Impact factor: 8.401

2.  Exosomes from iPSCs Delivering siRNA Attenuate Intracellular Adhesion Molecule-1 Expression and Neutrophils Adhesion in Pulmonary Microvascular Endothelial Cells.

Authors:  Zhihai Ju; Jinhui Ma; Chen Wang; Jie Yu; Yeru Qiao; Feilong Hei
Journal:  Inflammation       Date:  2017-04       Impact factor: 4.092

3.  Participation of lipopolysaccharide in hyperplasic adipose expansion: Involvement of NADPH oxidase/ROS/p42/p44 MAPK-dependent Cyclooxygenase-2.

Authors:  Chao-Chien Chang; Kee-Chin Sia; Jia-Feng Chang; Chia-Mo Lin; Chuen-Mao Yang; I-Ta Lee; Thi Thuy Tien Vo; Kuo-Yang Huang; Wei-Ning Lin
Journal:  J Cell Mol Med       Date:  2022-06-01       Impact factor: 5.295

4.  TLR4 Ligands Selectively Synergize to Induce Expression of IL-8.

Authors:  Lauren M Valenty; Christine M Longo; Carol Horzempa; Anthony Ambesi; Paula J McKeown-Longo
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-10-01       Impact factor: 4.730

5.  Haem oxygenase-1 up-regulation by rosiglitazone via ROS-dependent Nrf2-antioxidant response elements axis or PPARγ attenuates LPS-mediated lung inflammation.

Authors:  Rou-Ling Cho; Chien-Chung Yang; Hui-Ching Tseng; Li-Der Hsiao; Chih-Chung Lin; Chuen-Mao Yang
Journal:  Br J Pharmacol       Date:  2018-09-06       Impact factor: 8.739

6.  Up-regulation of NADPH oxidase-mediated redox signaling contributes to the loss of barrier function in KRIT1 deficient endothelium.

Authors:  Luca Goitre; Peter V DiStefano; Andrea Moglia; Nicholas Nobiletti; Eva Baldini; Lorenza Trabalzini; Julie Keubel; Eliana Trapani; Vladimir V Shuvaev; Vladimir R Muzykantov; Ingrid H Sarelius; Saverio Francesco Retta; Angela J Glading
Journal:  Sci Rep       Date:  2017-08-15       Impact factor: 4.379

7.  Inhibitor of Tec kinase, LFM-A13, decreases pro-inflammatory mediators production in LPS-stimulated RAW264.7 macrophages via NF-κB pathway.

Authors:  Fei Wang; Wei Zhang; Chao Wang; Xu Fang; Hao Cheng; Sheng Liu; Xu-Lin Chen
Journal:  Oncotarget       Date:  2017-05-23

8.  TLR4 modulates inflammatory gene targets in the retina during Bacillus cereus endophthalmitis.

Authors:  Phillip S Coburn; Frederick C Miller; Austin L LaGrow; Salai Madhumathi Parkunan; C Blake Randall; Rachel L Staats; Michelle C Callegan
Journal:  BMC Ophthalmol       Date:  2018-04-16       Impact factor: 2.209

9.  Metformin Inhibits Migration and Invasion by Suppressing ROS Production and COX2 Expression in MDA-MB-231 Breast Cancer Cells.

Authors:  Chandler Schexnayder; Kiera Broussard; Demitrius Onuaguluchi; Anthony Poché; Moamen Ismail; LeFontae McAtee; Shawn Llopis; Amber Keizerweerd; Harris McFerrin; Christopher Williams
Journal:  Int J Mol Sci       Date:  2018-11-21       Impact factor: 5.923

10.  Carbon monoxide releasing molecule-2 attenuates Pseudomonas aeruginosa-induced ROS-dependent ICAM-1 expression in human pulmonary alveolar epithelial cells.

Authors:  Chiang-Wen Lee; Cheng-Hsun Wu; Yao-Chang Chiang; Yuh-Lien Chen; Kuo-Ting Chang; Chu-Chun Chuang; I-Ta Lee
Journal:  Redox Biol       Date:  2018-07-04       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.